Market Tracker

04/23 12:04pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

4.14
Data as of 11:45am ET
 -0.0599 / -1.43%
Today’s Change
3.70
Today|||52-Week Range
5.81
+6.43%
Year-to-Date

Today’s Trading

Previous close4.20
Today’s open4.22
Day’s range4.09 - 4.22
Volume31,233
Average volume (3 months)216,830
Market cap$420.2M
Dividend yield--
Data as of 11:45am ET, 04/23/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-0.49-2.98%
RTRXRetrophin Inc-0.58-3.91%
OSIROsiris Therapeutics ...-0.04-0.30%
CGENCompugen Ltd-0.20-2.02%
Data as of 12:03pm ET, 04/23/2014

Financials

Next reporting dateMay 28, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
David Aviezer
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts